EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lesional Markers and Precursors of Melanoma

Valerie Foy, Graham H Litchman

Dermatologic Clinics · 2025

DOI: 10.1016/j.det.2025.03.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Valerie Foy und 1 weiteren Autor:innen. Beteiligte Einrichtung: St. John's Episcopal Hospital, Department of Dermatology, Far Rockaway, NY 11691, USA. Electronic address: valerie.foy15@gmail.com. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a malignant skin tumor with increasing global incidence, driven by factors like UV exposure and genetic predisposition. Early detection is critical, with markers such as atypical nevi and lentigo maligna indicating potential melanoma progression. Genetic mutations (eg, CDKN2A, NRAS) influence melanoma risk and tumor behavior, aiding risk assessment and targeted treatments. Dermoscopic and histologic tools, including the ABCDE criteria and biomarkers like S100B, improve diagnostic accuracy. Timely intervention, along with advancements in genetic testing, dermoscopy, and AI-assisted tools, are essential for reducing melanoma's morbidity and mortality. Regular surveillance for high-risk individuals is crucial for early identification and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsBiomarkers, TumorHumansDermoscopyS100 Calcium Binding Protein beta SubunitHutchinson's Melanotic FreckleEarly Detection of CancerGTP PhosphohydrolasesCyclin-Dependent Kinase Inhibitor p16Dysplastic Nevus SyndromeMembrane Proteins

Stichwörter der Autor:innen

Atypical neviLesional marker of melanomaMelanocytic neviPrecursor of melanoma

Substanzen

Biomarkers, TumorNRAS protein, humanS100 Calcium Binding Protein beta SubunitGTP PhosphohydrolasesS100B protein, humanCyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanMembrane Proteins

Autor:innen und Institutionen

  • St. John's Episcopal Hospital, Department of Dermatology, Far Rockaway, NY 11691, USA. Electronic address: valerie.foy15@gmail.com.
  • Department of Dermatology, Vivida Dermatology, Touro University Nevada, 6460 Medical Center Street, Las Vegas, NV 89148, USA.

Zitieren

APA

Foy, V., & Litchman, G. H. (2025). Lesional Markers and Precursors of Melanoma. Dermatologic Clinics. https://doi.org/10.1016/j.det.2025.03.007

Vancouver

Foy V, Litchman GH. Lesional Markers and Precursors of Melanoma. Dermatologic Clinics. 2025. doi:10.1016/j.det.2025.03.007

BibTeX
@article{Foy2025,
  author = {Foy, Valerie and Litchman, Graham H},
  title = {Lesional Markers and Precursors of Melanoma},
  journal = {Dermatologic Clinics},
  year = {2025},
  doi = {10.1016/j.det.2025.03.007}
}
Kostenlos starten →